 <h1>Umeclidinium Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to umeclidinium: inhalation powder</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, umeclidinium may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking umeclidinium:</p><p>
<i>Less common</i>
</p><ul>
<li>Bladder pain</li>
<li>bloody or cloudy urine</li>
<li>body aches or pain</li>
<li>chest pain</li>
<li>chills</li>
<li>cough</li>
<li>difficult, burning, or painful urination</li>
<li>difficulty with breathing</li>
<li>dryness or soreness of the throat</li>
<li>ear congestion</li>
<li>fast, pounding, or irregular heartbeat or pulse</li>
<li>fever</li>
<li>frequent urge to urinate</li>
<li>hoarseness</li>
<li>loss of voice</li>
<li>lower back or side pain</li>
<li>sneezing</li>
<li>sore throat</li>
<li>tender, swollen glands in the neck</li>
<li>tightness in the chest</li>
<li>trouble in swallowing</li>
<li>unusual tiredness or weakness</li>
<li>voice changes</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Dizziness</li>
<li>fainting</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Blindness</li>
<li>blurred vision</li>
<li>decreased urination</li>
<li>difficulty in passing urine (dribbling)</li>
<li>eye pain or discomfort</li>
<li>hives, itching, skin rash</li>
<li>hoarseness</li>
<li>irritation</li>
<li>joint pain, stiffness, or swelling</li>
<li>large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or genitals</li>
<li>nausea</li>
<li>redness of the skin</li>
<li>swelling of the eyelids, face, lips, hands, or feet</li>
<li>tearing</li>
<li>tightness in the chest</li>
<li>troubled swallowing</li>
<li>vomiting</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of umeclidinium may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>Less common</i>
</p><ul>
<li>Back, neck, arm, or leg pain</li>
<li>belching</li>
<li>bruise</li>
<li>depression</li>
<li>diarrhea</li>
<li>difficulty in moving</li>
<li>dizziness or lightheadedness</li>
<li>feeling of constant movement of self or surroundings</li>
<li>heartburn</li>
<li>indigestion</li>
<li>muscle cramps or stiffness</li>
<li>sensation of spinning</li>
<li>stomach discomfort, upset, or pain toothache</li>
<li>upper abdominal or stomach pain</li>
</ul><p>
<!-- end inhalation powder --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to umeclidinium: inhalation powder</i></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Tachycardia, hypertension, sinus tachycardia (greater than or equal to 1%)</p>
<p><b>Uncommon</b> (0.1% to 1%): Atrial fibrillation, idioventricular rhythm, supraventricular tachycardia, supraventricular extrasystoles<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Upper abdominal pain, toothache, dyspepsia (greater or equal to 1%), diarrhea (greater or equal to 1%), nausea (greater or equal to 1%)</p>
<p><b>Uncommon</b> (0.1% to 1%): Constipation, dry mouth<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection</p>
<p><b>Frequency not reported</b>: Worsening of urinary retention<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Arthralgia, myalgia, back pain, neck pain (greater or equal to 1%), pain in extremity (greater or equal to 1%)<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache, sinus headache (greater or equal to 1%), dizziness (greater or equal to 1%)</p>
<p><b>Uncommon</b> (0.1% to 1%): Dysgeusia<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Contusion, vertigo (greater or equal to 1%)<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Depression (greater or equal to 1%)<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Nasopharyngitis, upper respiratory tract infection, viral respiratory tract infection, cough, sinusitis, pneumonia (greater than or equal to 1%), lower respiratory tract infection (greater than or equal to 1%), rhinitis (greater than or equal to 1%), oropharyngeal pain (greater than or equal to 1%)</p>
<p><b>Uncommon</b> (0.1% to 1%): Pharyngitis<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Worsening of narrow-angle glaucoma (eye pain or discomfort, blurred vision, visual halos or colored images in association with red eyes from conjunctival congestion and corneal edema)<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. "Product Information. Incruse Ellipta (umeclidinium)." GlaxoSmithKline, Research Triangle Park, NC. </p><p id="ref_3">3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p></div>
<div class="more-resources" id="moreResources">
<h2>More about umeclidinium</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Espa√±ol</li>
<li>25 Reviews</li>
<li>Drug class: anticholinergic bronchodilators</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Umeclidinium Inhalation &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Incruse Ellipta</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>COPD, Maintenance</li>
<li>COPD</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to umeclidinium: inhalation powder</i></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Tachycardia, hypertension, sinus tachycardia (greater than or equal to 1%)</p><p><b>Uncommon</b> (0.1% to 1%): Atrial fibrillation, idioventricular rhythm, supraventricular tachycardia, supraventricular extrasystoles<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Upper abdominal pain, toothache, dyspepsia (greater or equal to 1%), diarrhea (greater or equal to 1%), nausea (greater or equal to 1%)</p><p><b>Uncommon</b> (0.1% to 1%): Constipation, dry mouth<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection</p><p><b>Frequency not reported</b>: Worsening of urinary retention<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Arthralgia, myalgia, back pain, neck pain (greater or equal to 1%), pain in extremity (greater or equal to 1%)<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache, sinus headache (greater or equal to 1%), dizziness (greater or equal to 1%)</p><p><b>Uncommon</b> (0.1% to 1%): Dysgeusia<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Contusion, vertigo (greater or equal to 1%)<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Depression (greater or equal to 1%)<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Nasopharyngitis, upper respiratory tract infection, viral respiratory tract infection, cough, sinusitis, pneumonia (greater than or equal to 1%), lower respiratory tract infection (greater than or equal to 1%), rhinitis (greater than or equal to 1%), oropharyngeal pain (greater than or equal to 1%)</p><p><b>Uncommon</b> (0.1% to 1%): Pharyngitis<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Worsening of narrow-angle glaucoma (eye pain or discomfort, blurred vision, visual halos or colored images in association with red eyes from conjunctival congestion and corneal edema)<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. "Product Information. Incruse Ellipta (umeclidinium)." GlaxoSmithKline, Research Triangle Park, NC. </p><p id="ref_3">3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><h2>More about umeclidinium</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Espa√±ol</li>
<li>25 Reviews</li>
<li>Drug class: anticholinergic bronchodilators</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Umeclidinium Inhalation &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>COPD, Maintenance</li>
<li>COPD</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>